The estimated Net Worth of Laura K Campbell is at least $1.61 Million dollars as of 16 March 2021. Ms. Campbell owns over 10,000 units of Athersys Inc stock worth over $41,096 and over the last 15 years she sold ATHX stock worth over $908,491. In addition, she makes $664,617 as Senior Vice President - Finance at Athersys Inc.
Sign up
Ms. Campbell ATHX stock SEC Form 4 insiders trading
Laura has made over 9 trades of the Athersys Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently she sold 10,000 units of ATHX stock worth $19,700 on 16 March 2021.
The largest trade she's ever made was selling 234,306 units of Athersys Inc stock on 30 March 2020 worth over $782,582. On average, Laura trades about 8,276 units every 83 days since 2009. As of 16 March 2021 she still owns at least 403,692 units of Athersys Inc stock.
You can see the complete history of Ms. Campbell stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Laura Campbell biography
Laura K. Campbell CPA serves as Senior Vice President - Finance of the Company. Ms. Campbell joined Athersys in January 1998 and has served as our Senior Vice President of Finance since March 2016. Ms. Campbell joined us as Controller from January 1998, followed by Director of Finance and Senior Director of Finance, and then served as our Vice President of Finance from June 2006 until March 2016. Prior to Athersys, she was at Ernst & Young LLP, a public accounting firm, for eleven years in the firm’s audit practice. During her tenure with Ernst & Young LLP, Ms. Campbell specialized in entrepreneurial services and the biotechnology industry sector and assisted in several initial public offerings. Ms. Campbell received her B.S., with distinction, in Business Administration from The Ohio State University and is a Certified Public Accountant.
What is the salary of Laura Campbell?
As the Senior Vice President - Finance of Athersys Inc, the total compensation of Laura Campbell at Athersys Inc is $664,617. There are 3 executives at Athersys Inc getting paid more, with Gil Van Bokkelen having the highest compensation of $1,596,650.
How old is Laura Campbell?
Laura Campbell is 56, she's been the Senior Vice President - Finance of Athersys Inc since 2016. There are 7 older and 7 younger executives at Athersys Inc. The oldest executive at Athersys Inc is Lorin Randall, 76, who is the Independent Director.
Insiders trading at Athersys Inc
Over the last 17 years, insiders at Athersys Inc have traded over $3,715,462 worth of Athersys Inc stock and bought 2,242,389 units worth $3,620,264 . The most active insiders traders include Advisors Llc Orbi Med Capit..., Michael B Sheffery und Jordan Davis. On average, Athersys Inc executives and independent directors trade stock every 43 days with the average trade being worth of $3,231. The most recent stock trade was executed by Daniel A. Camardo on 22 November 2022, trading 100,000 units of ATHX stock currently worth $55,000.
What does Athersys Inc do?
athersys is a clinical stage biopharmaceutical company with a growing pipeline of highly differentiated, potential best in class therapeutics to treat significant and life-threatening diseases. we are engaged in the discovery and development of innovative new medicines designed to extend and enhance the quality of human life. through the application of our proprietary technologies, we have established a pipeline of therapeutic product development programs in multiple disease areas. this pipeline includes both stem cell therapy and pharmaceuticals.
What does Athersys Inc's logo look like?
Complete history of Ms. Campbell stock trades at Athersys Inc
Athersys Inc executives and stock owners
Athersys Inc executives and other stock owners filed with the SEC include:
-
Gil Van Bokkelen,
Chairman of the Board, Chief Executive Officer -
John Harrington,
Executive Vice President, Chief Scientific Officer, Director -
William Lehmann,
President, Chief Operating Officer -
Laura Campbell,
Senior Vice President - Finance -
Ivor Macleod CPA, M.B.A.,
Chief Financial Officer & Principal Accounting Officer -
Dr. John J. Harrington,
Co-Founder, Chief Scientific Officer, Exec. VP & Director -
William B. J. Lehmann Jr., M.B.A., J.D., MBA,
Pres, COO, Sec. & Interim CEO -
Lorin Randall,
Independent Director -
Jack Wyszomierski,
Independent Director -
Ismail Kola,
Independent Director -
Jane Wasman,
Director -
Baiju Shah,
Director -
Katherine Kalin,
Director -
Hardy Kagimoto,
Director -
Maia Hansen,
Senior Vice President - Operations, Supply Chain -
Ivor Macleod,
Chief Financial Officer -
Dr. Eric Jenkins M.D.,
Sr. Medical Director & Head of Clinical Operations -
Maia Hansen M.B.A., M.S.,
Sr. VP and Head of Operations & Supply Chain -
Rakesh Ramachandran,
Head of Information Technology & Communications and VP -
Dr. Robert Mays Ph.D.,
VP of Regenerative Medicine & Head of Neuroscience Programs -
Dr. Manal Morsy M.D., PH.D.,
Sr. VP & Head of Global Regulatory Affairs -
Alison O'Sullivan M.B.A.,
Sr. Director of HR -
Karen Hunady M.S.,
Director of Corp. Communications & Investor Relations -
Jordan Davis,
Director -
Lee Babiss,
Director -
Neema Mayhugh,
Director -
Joseph Patrick Nolan,
Director -
K.K. Healios,
-
Tadahisa Kagimoto,
Director -
Robert J Deans,
Sr. Vice President -
Kenneth Traub,
Director -
Advisors Llc Orbi Med Capit...,
-
George M Jr Milne,
Director -
Floyd D Md Loop,
Director -
Advisors Llcisaly Samuel D ...,
-
Michael B Sheffery,
Director -
William C Mulligan,
Director -
Daniel A. Camardo,
CEO